3,269
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy

, , , , , , , & show all
Pages 807-814 | Received 17 Jan 2018, Accepted 09 Mar 2018, Published online: 19 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Daijie Fu, Zhe Ni, Kerong Wu, Peng Cheng, Xiaofeng Ji, Guoyuan Li & Xifu Shang. (2021) A novel redox-responsive ursolic acid polymeric prodrug delivery system for osteosarcoma therapy. Drug Delivery 28:1, pages 195-205.
Read now
Wanfu Men, Peiyao Zhu, Siyuan Dong, Wenke Liu, Kun Zhou, Yu Bai, Xiangli Liu, Shulei Gong & Shuguang Zhang. (2020) Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy in vivo. Drug Delivery 27:1, pages 180-190.
Read now

Articles from other publishers (22)

Ramakrishna Thilagar Uma Maheswari, Velmurugan Ajithkumar, Perumal Varalakshmi & Mariappan Rajan. (2023) CD44 tagged hyaluronic acid - chitosan liposome carrier for the delivery of berberine and doxorubicin into lung cancer cells. International Journal of Biological Macromolecules 253, pages 126599.
Crossref
Sofia A. G. Monteiro, Pedro M. P. Gois & João P. M. António. (2023) Boronic Acids and Beyond: ROS-Responsive Prodrugs as Tools for a Safer and More Effective Cancer Chemotherapy. Synlett.
Crossref
Qing Pei, Bowen Jiang, Dengyuan Hao & Zhigang Xie. (2023) Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics. Acta Pharmaceutica Sinica B 13:8, pages 3252-3276.
Crossref
Daoyang Fan, Chaoqi Zhang, Hufei Wang, Qingguang Wei, Hong Cai, Feng Wei, Zhilei Bian, Weifeng Liu, Xing Wang & Zhongjun Liu. (2023) Fabrication of a composite 3D-printed titanium alloy combined with controlled in situ drug release to prevent osteosarcoma recurrence. Materials Today Bio 20, pages 100683.
Crossref
Zhiyang Cheng, Ying Huang, Pingxuan Shao, Lei Wang, Shulei Zhu, Jiahui Yu & Wei Lu. (2021) Hypoxia-Activated Albumin-Binding Exatecan Prodrug for Cancer Therapy. ACS Omega 7:1, pages 1082-1089.
Crossref
Javad Sharifi-Rad, Cristina Quispe, Jayanta Kumar Patra, Yengkhom Disco Singh, Manasa Kumar Panda, Gitishree Das, Charles Oluwaseun Adetunji, Olugbenga Samuel Michael, Oksana Sytar, Letizia Polito, Jelena Živković, Natália Cruz-Martins, Marta Klimek-Szczykutowicz, Halina Ekiert, Muhammad Iqbal Choudhary, Seyed Abdulmajid Ayatollahi, Bekzat Tynybekov, Farzad Kobarfard, Ana Covilca Muntean, Ioana Grozea, Sevgi Durna Daştan, Monica Butnariu, Agnieszka Szopa & Daniela Calina. (2021) Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy. Oxidative Medicine and Cellular Longevity 2021, pages 1-24.
Crossref
Jasleen Kaur, Vikrant Mehta & Gurpreet Kaur. (2021) Preparation, development and characterization of Leucaena leucocephala galactomannan (LLG) conjugated sinapic acid: A potential colon targeted prodrug. International Journal of Biological Macromolecules 178, pages 29-40.
Crossref
Luzhou Xu, Lei Zhu, Kai Zheng, Junlou Liu, Panpan Tian, Di Hu, Qianqian Wang, Qiaoyun Zuo, Xiaosong Ouyang, Yanna Dai, Yuxian Fu, Xinyi Dai, Fang Huang & Jun Cheng. (2021) The design and synthesis of redox-responsive oridonin polymeric prodrug micelle formulation for effective gastric cancer therapy. Journal of Materials Chemistry B 9:13, pages 3068-3078.
Crossref
Mingyu Wang, Li Zhang, Yanfei Cai, Yang Yang, Lipeng Qiu, Yiting Shen, Jian Jin, Juan Zhou & Jinghua Chen. (2020) Bioengineered Human Serum Albumin Fusion Protein as Target/Enzyme/pH Three-Stage Propulsive Drug Vehicle for Tumor Therapy. ACS Nano 14:12, pages 17405-17418.
Crossref
Parastou Rahimizadeh, Sungtae Yang & Sung In Lim. (2020) Albumin: An Emerging Opportunity in Drug Delivery. Biotechnology and Bioprocess Engineering 25:6, pages 985-995.
Crossref
Qunye He, Jun Chen, Jianhua Yan, Shundong Cai, Hongjie Xiong, Yanfei Liu, Dongming Peng, Miao Mo & Zhenbao Liu. (2020) Tumor microenvironment responsive drug delivery systems. Asian Journal of Pharmaceutical Sciences 15:4, pages 416-448.
Crossref
Hossein Rahimi, Marziyeh Salehiabar, Soodabeh Davaran, Hossein Danafar & Hamed Nosrati. 2020. Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications. Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications 247 270 .
Jorge Peiró Cadahía, Viola Previtali, Nikolaj S. Troelsen & Mads H. Clausen. (2019) Prodrug strategies for targeted therapy triggered by reactive oxygen species. MedChemComm 10:9, pages 1531-1549.
Crossref
Archie Wall, Karl Nicholls, Mikael B. Caspersen, Stig Skrivergaard, Kenneth A. Howard, Kersti Karu, Vijay Chudasama & James R. Baker. (2019) Optimised approach to albumin–drug conjugates using monobromomaleimide-C-2 linkers. Organic & Biomolecular Chemistry 17:34, pages 7870-7873.
Crossref
Duane Gischewski Pereira, Mariana Manzano Rendeiro, Vanessa Faria Cortes, Leandro Augusto Barbosa & Luis Eduardo M. Quintas. (2019) Antagonistic anticancer effect of paclitaxel and digoxin combination. Journal of Cellular Biochemistry 120:8, pages 13107-13114.
Crossref
Jun Li, Zu-E. Hu, Xian-Ling Yang, Wan-Xia Wu, Xiu Xing, Bo Gu, Yan-Hong Liu, Na Wang & Xiao-Qi Yu. (2019) GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency. Biomaterials Science 7:8, pages 3277-3286.
Crossref
Ya‐Nan Xue, Bing‐Bing Yu, Ya‐Nan Liu, Rui Guo, Jiu‐Ling Li, Li‐Chao Zhang, Jing Su, Lian‐Kun Sun & Yang Li. (2019) Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial‐mesenchymal transition and inducing apoptosis. The Prostate 79:6, pages 647-656.
Crossref
Qing Pei, Xiuli Hu, Xiaohua Zheng, Rui Xia, Shi Liu, Zhigang Xie & Xiabin Jing. (2019) Albumin-bound paclitaxel dimeric prodrug nanoparticles with tumor redox heterogeneity-triggered drug release for synergistic photothermal/chemotherapy. Nano Research 12:4, pages 877-887.
Crossref
Chao Tao, Yon Jin Chuah, Chenjie Xu & Dong-An Wang. (2019) Albumin conjugates and assemblies as versatile bio-functional additives and carriers for biomedical applications. Journal of Materials Chemistry B 7:3, pages 357-367.
Crossref
Ryan Clay & Shadab A. Siddiqi. 2019. Theranostic Approach for Pancreatic Cancer. Theranostic Approach for Pancreatic Cancer 325 367 .
Pengfei Zhao, Yonghui Wang, Aihua Wu, Yuefeng Rao & Yongzhuo Huang. (2018) Roles of Albumin‐Binding Proteins in Cancer Progression and Biomimetic Targeted Drug Delivery. ChemBioChem 19:17, pages 1796-1805.
Crossref
Wei Wei, Cong Luo, Jincheng Yang, Bingjun Sun, Dongyang Zhao, Yan Liu, Yingli Wang, Wenqian Yang, Qiming Kan, Jin Sun & Zhonggui He. (2018) Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer. Journal of Controlled Release 285, pages 187-199.
Crossref